Galera Therapeutics, Inc. (GRTX)
NASDAQ: GRTX · IEX Real-Time Price · USD
0.184
-0.002 (-1.08%)
Apr 19, 2024, 4:00 PM EDT - Market closed
Galera Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Galera Therapeutics stock have an average target of 0.35, with a low estimate of 0.25 and a high estimate of 0.50. The average target predicts an increase of 90.22% from the current stock price of 0.18.
Analyst Consensus: Hold
* Price targets were last updated on Aug 29, 2023.
Analyst Ratings
The average analyst rating for GRTX stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $0.4 → $0.25 | Hold | Maintains | $0.4 → $0.25 | +35.87% | Aug 29, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $6 → $0.3 | Strong Buy → Hold | Downgrades | $6 → $0.3 | +63.04% | Aug 16, 2023 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $6 → $0.5 | Buy → Hold | Downgrades | $6 → $0.5 | +171.74% | Aug 10, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +3,160.87% | Jul 17, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $6 | Strong Buy | Maintains | $10 → $6 | +3,160.87% | Mar 22, 2023 |
Financial Forecast
Revenue This Year
25.50M
Revenue Next Year
127.02M
from 25.50M
Increased by 398.12%
EPS This Year
-1.26
from -1.33
EPS Next Year
-0.80
from -1.26
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | 52.5M | 130.8M |
| Avg | 25.5M | 127.0M |
| Low | n/a | 122.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | - | 412.8% |
| Avg | - | 398.1% |
| Low | - | 378.6% |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -1.30 | -0.82 |
| Avg | -1.26 | -0.80 |
| Low | -1.22 | -0.77 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.